Experimental comparative assessment of butanol or ethanol diesel-fuel extenders impact on combustion features, cyclic irregularity, and regulated emissions balance in heavy-duty diesel engine

Autor: Rakopoulos, Constantine D., Rakopoulos, Dimitrios C., Kosmadakis, George M., Papagiannakis, Roussos G.

Publikováno v: In Energy 1 May 2019 174:1145-1157

Digital endpoints in clinical trials: emerging themes from a multi-stakeholder Knowledge Exchange event.

Autor: Tackney MS; MRC-Biostatistics Unit, University of Cambridge, Cambridge, UK. mst35@cam.ac.uk., Steele A; Strategic Funding Partnerships Hub (SFPH), Cambridge University Hospitals, Cambridge, UK., Newman J; Department of Medicine, University of Cambridge and Royal Papworth Hospital, Cambridge, UK., Fritzsche MC; Institute of History and Ethics in Medicine, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.; School of Social Sciences and Technology, Technical University of Munich, Munich, Germany., Lucivero F; Ethox Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Khadjesari Z; School of Health Sciences, University of East Anglia, Norwich, England., Lynch J; University of Hertfordshire, Hatfield, UK., Abbott RA; ICON PLC, Reading, UK., Barber VS; Oxford Clinical Trials Research Unit (OCTRU), University of Oxford, Oxford, UK., Carpenter JR; MRC Clinical Trials Unit at University College London, London, UK.; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK., Copsey B; Leeds Clinical Trials Research Unit, University of Leeds, Leeds, UK., Davies EH; Aparito, a wholly owned subsidiary company of Eli Lilly and Company, Wrexham, Wales, UK., Dixon WG; Centre for Epidemiology Versus Arthritis, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK., Fox L; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK., González J; Microsoft Research Cambridge, Cambridge, UK., Griffiths J; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK., Hinchliffe CHL; Translational and Clinical Research Institute, Newcastle University, Newcastle, UK., Kolanko MA; UK Dementia Research Institute Care Research and Technology Centre, London, UK.; Imperial College London, London, UK., McGagh D; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK., Rodriguez A; The University of Edinburgh, Edinburgh, UK., Roussos G; School of Computing and Mathematical Sciences, Birkbeck College, University of London, London, UK., So KBE; Alexion Rare Oncology, AstraZeneca, Cambridge, UK., Stanton L; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK., Toshner M; Royal Papworth Hospital and Department of Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK., Varian F; University of Sheffield, Sheffield, UK., Williamson PR; Institute of Population Health, University of Liverpool, Liverpool, UK., Yimer BB; Centre for Epidemiology, University of Manchester, Manchester, UK., Villar SS; MRC-Biostatistics Unit, University of Cambridge, Cambridge, UK.

Publikováno v: Trials [Trials] 2024 Aug 03; Vol. 25 (1), pp. 521. Date of Electronic Publication: 2024 Aug 03.

A smartphone-based tapping task as a marker of medication response in Parkinson's disease: a proof of concept study.

Autor: Broeder S; KU Leuven, Department of Rehabilitation Sciences, Neurorehabilitation Research Group (eNRGy), Tervuursevest 101, 3001, Leuven, Belgium. sannebroeder@live.com., Roussos G; Department of Computer Science and Information Systems, Birkbeck College, University of London, Malet Street, London, WC1E 7HX, UK., De Vleeschhauwer J; KU Leuven, Department of Rehabilitation Sciences, Neurorehabilitation Research Group (eNRGy), Tervuursevest 101, 3001, Leuven, Belgium., D'Cruz N; KU Leuven, Department of Rehabilitation Sciences, Neurorehabilitation Research Group (eNRGy), Tervuursevest 101, 3001, Leuven, Belgium., de Xivry JO; KU Leuven, Department of Kinesiology, Movement Control and Neuroplasticity Research Group, Tervuursevest 101, 3001, Leuven, Belgium.; KU Leuven, KU Leuven Brain Institute, Leuven, Belgium., Nieuwboer A; KU Leuven, Department of Rehabilitation Sciences, Neurorehabilitation Research Group (eNRGy), Tervuursevest 101, 3001, Leuven, Belgium.; KU Leuven, KU Leuven Brain Institute, Leuven, Belgium.

Publikováno v: Journal of neural transmission (Vienna, Austria : 1996) [J Neural Transm (Vienna)] 2023 Jul; Vol. 130 (7), pp. 937-947. Date of Electronic Publication: 2023 Jun 02.

Marine Exhaust Gas Treatment Systems for Compliance with the IMO 2020 Global Sulfur Cap and Tier III NOx Limits: A Review

Autor: Theodoros C. Zannis, John S. Katsanis, Georgios P. Christopoulos, Elias A. Yfantis, Roussos G. Papagiannakis, Efthimios G. Pariotis, Dimitrios C. Rakopoulos, Constantine D. Rakopoulos, Athanasios G. Vallis

Publikováno v: Energies, Vol 15, Iss 10, p 3638 (2022)

In the present work, the contemporary exhaust gas treatment systems (EGTS) used for SOx, PM, and NOx emission mitigation from shipping are reviewed. Specifically, after-treatment technologies such as wet scrubbers with seawater and freshwater solutio

Externí odkaz: https://doaj.org/article/5e98817449bd41638fe109971d226b91

MarketLine Company Profile: Revoil S.A.

Publikováno v: Revoil S.A. MarketLine Company Profile. 9/29/2024, p1-12. 12p.